Work

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma

Year: 2008

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.23313

Authors: Scott H. Okuno, Robert Delaune, Jeff A. Sloan, Nathan R. Foster, Matthew J. Maurer, Marie‐Christine Aubry, Kendrith M. Rowland, Gamini S. Soori, Daniel A. Nikcevich, Carl G. Kardinal, Donald W. Northfelt, Alex A. Adjei

Institutions: Mayo Clinic, Metro-Minnesota Community Oncology Research Consortium, Missouri Valley Cancer Consortium, Scottsdale Community College

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1094409381, G1109514914, G1268312386, G1423238671, G1539327064, G179864828, Illinois Oncology Research Association Community Clinical Oncology Program, Sanford Community Cancer Consortium, G2082142344, G2397742718, G248987615, Geisinger Clinical Oncology Program, MICHIGAN CANCER RESEARCH CONSORTIUM CCOP, G358241105, G3789417232, G42877212, TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, G6109875642, North Central Cancer Treatment Group, Gulf Coast MBCCOP, Cedar Rapids Oncology Project, Carle Cancer Center Community Clinical Oncology Program, G688707633, Community Clinical Oncology Program, Duluth Community Clinical Oncology Program, G844520391, Iowa Oncology Research Association, Scottsdale Community Clinical Oncology Program, Mayo Clinic Comprehensive Cancer Center Support Grant, G937543590

OpenAlex ID: W2018900164

FWCI: 0.922

Cites: 29

Cited by: 16

Related to: 10